Loading
A phase 1 trial of MAQ-001 run by MabQuest SA, now recruiting.
MAQ-001 in Patients With Advanced Solid Tumors is a phase 1 interventional study registered as NCT06514651 by MabQuest SA, with 30 participants planned, started 2024-06-06. Conditions recorded: Advanced Solid Tumor. Interventions recorded: MAQ-001 and Ipilimumab.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/